You can access any of the podium or poster presentations’ abstracts by searching for it below.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
Short-term esomeprazole treatment resolves reflux symptoms in patients with nonerosive symptomatic gastro-oesophageal reflux disease (gord) and frequent heartburn
- In: Posters: Community Pharmacy: Better outcomes for tomorrow
- At: Bangkok (Thailand) (2014)
- Type: Poster
- Poster code: POS-CPS141
- By: KATZ, Philip (Einstein Medical Center, Division of Gastroenterology, Philadelphia, United States of America)
- Co-author(s): Le Moigne, Anne (Pfizer Consumer Healthcare, Madison, United States of America)
Park, Kelly (Pfizer Consumer Healthcare, Madison, United States of America)
Pollack, Charles (Pfizer Consumer Healthcare, Madison, United States of America) - Abstract:
Background: Pharmacists are often asked about short-term treatments of reflux symptoms such as heartburn (HB) and acid regurgitation. We evaluated 14-day efficacy from 2 similarly designed randomized controlled studies of esomeprazole (ESO) 20 mg and 40 mg in patients likely to seek self-treatment in a pharmacy setting.
Setting: Study 1 (N=368).. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 2 July 2026